News

Almacs Clinical Technologies Division Undergoes Successful Joint GCP-GMP MHRA Inspection

September 21st 2010

Parexel Announces Strategic Functional Service Provider Relationship With Eli Lilly and Company for Clinical Development in Asia/Pacific Region

September 21st 2010

CEDRA Corporation Announces New Company Name

September 21st 2010

Medco Completes Acquisition of United BioSource Corporation

September 17th 2010

The Open Source Effect: Akaza Research Provides Insight into Rapid Growth of OpenClinica

September 17th 2010

Info for Authors

September 17th 2010

DaVita Clinical Research Expands Reach of Services at Central Laboratory

September 16th 2010

Clearstone Reporting HbA1c Result Values in IFCC and NGSP Units for All Clinical Trials Globally

September 16th 2010

Covance Expands Asia-Pacific Presence with Dedicated Central Laboratory in Japan

September 15th 2010

i3 Expands Partnership With Eli Lilly and Company

September 14th 2010

Virtify Simplifies PIM Labeling with New Software Release

September 14th 2010

Ricerca Biosciences/Instem Collaboration Delivers Improved Quality in Drug Safety Studies

September 14th 2010

Increase in Trials in Emerging Regions

September 13th 2010

ICR Expands into Asia Pacific with PACRA

September 13th 2010

Changing Relationships Between Pharmaceutical Companies and Their Outsourced Providers

September 13th 2010

Part II Scope and Application Guidance from FDA

September 13th 2010

Berger & Boyer, Inc was established in 1976 as a CRO.

September 13th 2010

Research Questioned

September 13th 2010

Patient Self Assessments Become More Popular

September 13th 2010

Phlexglobal launches eTMF Consulting Group

September 13th 2010

Good Clinical Practice (GCP) guidelines implemented.

September 13th 2010

FDA Revises Medical Device Regulations and Human Subject Protection Requirements

September 13th 2010

Hatch-Waxman Act

September 13th 2010

Berger & Boyer, Inc was established in 1976 as a CRO.

September 13th 2010

Many CRO's Begin to Establish

September 13th 2010

Changing Public Perception of the Pharmaceutical Industry

September 13th 2010

Thorough QT Trials

September 13th 2010

FDA on CV Risk in Diabetics

September 13th 2010

PRA International Plans to Open New BioAnalytical Laboratory

September 13th 2010

Personal Computers Take the World by Storm

September 13th 2010

News

Almacs Clinical Technologies Division Undergoes Successful Joint GCP-GMP MHRA Inspection

Parexel Announces Strategic Functional Service Provider Relationship With Eli Lilly and Company for Clinical Development in Asia/Pacific Region

CEDRA Corporation Announces New Company Name

Medco Completes Acquisition of United BioSource Corporation

The Open Source Effect: Akaza Research Provides Insight into Rapid Growth of OpenClinica

Info for Authors

DaVita Clinical Research Expands Reach of Services at Central Laboratory

Clearstone Reporting HbA1c Result Values in IFCC and NGSP Units for All Clinical Trials Globally

Covance Expands Asia-Pacific Presence with Dedicated Central Laboratory in Japan

i3 Expands Partnership With Eli Lilly and Company

Virtify Simplifies PIM Labeling with New Software Release

Ricerca Biosciences/Instem Collaboration Delivers Improved Quality in Drug Safety Studies

Increase in Trials in Emerging Regions

ICR Expands into Asia Pacific with PACRA

Changing Relationships Between Pharmaceutical Companies and Their Outsourced Providers

Part II Scope and Application Guidance from FDA

Berger & Boyer, Inc was established in 1976 as a CRO.

Research Questioned

Patient Self Assessments Become More Popular

Phlexglobal launches eTMF Consulting Group

Good Clinical Practice (GCP) guidelines implemented.

FDA Revises Medical Device Regulations and Human Subject Protection Requirements

Hatch-Waxman Act

Berger & Boyer, Inc was established in 1976 as a CRO.

Many CRO's Begin to Establish

Changing Public Perception of the Pharmaceutical Industry

Thorough QT Trials

FDA on CV Risk in Diabetics

PRA International Plans to Open New BioAnalytical Laboratory

Personal Computers Take the World by Storm

Trending on Applied Clinical Trials Online

When AI Learns to Speak Every Language: An eCOA Migration Study

Upskilling Community Cancer Centers: A Training Pilot Hints at Promising Ways to Boost Oncology Clinical Research

FDA Outlines New Superiority Standard for Future CAR-T Approvals

ACT Brief: AI-Enabled COA Migration, Expanding Trial Footprints into Routine Care, and New FDA Approval in Myasthenia Gravis

Integrating Trials into Routine Care

News

Almac&#146;s Clinical Technologies Division Undergoes Successful Joint GCP-GMP MHRA Inspection

Parexel Announces Strategic Functional Service Provider Relationship With Eli Lilly and Company for Clinical Development in Asia/Pacific Region

CEDRA Corporation Announces New Company Name

Medco Completes Acquisition of United BioSource Corporation

The Open Source Effect: Akaza Research Provides Insight into Rapid Growth of OpenClinica

Info for Authors

DaVita Clinical Research Expands Reach of Services at Central Laboratory

Clearstone Reporting HbA1c Result Values in IFCC and NGSP Units for All Clinical Trials Globally

Covance Expands Asia-Pacific Presence with Dedicated Central Laboratory in Japan

i3 Expands Partnership With Eli Lilly and Company

Virtify Simplifies PIM Labeling with New Software Release

Ricerca Biosciences/Instem Collaboration Delivers Improved Quality in Drug Safety Studies

Increase in Trials in Emerging Regions

ICR Expands into Asia Pacific with PACRA

Changing Relationships Between Pharmaceutical Companies and Their Outsourced Providers

Part II Scope and Application Guidance from FDA

Berger & Boyer, Inc was established in 1976 as a CRO.

Research Questioned

Patient Self Assessments Become More Popular

Phlexglobal launches eTMF Consulting Group

Good Clinical Practice (GCP) guidelines implemented.

FDA Revises Medical Device Regulations and Human Subject Protection Requirements

Hatch-Waxman Act

Berger & Boyer, Inc was established in 1976 as a CRO.

Many CRO's Begin to Establish

Changing Public Perception of the Pharmaceutical Industry

Thorough QT Trials

FDA on CV Risk in Diabetics

PRA International Plans to Open New BioAnalytical Laboratory

Personal Computers Take the World by Storm

Trending on Applied Clinical Trials Online

When AI Learns to Speak Every Language: An eCOA Migration Study

Upskilling Community Cancer Centers: A Training Pilot Hints at Promising Ways to Boost Oncology Clinical Research

FDA Outlines New Superiority Standard for Future CAR-T Approvals

ACT Brief: AI-Enabled COA Migration, Expanding Trial Footprints into Routine Care, and New FDA Approval in Myasthenia Gravis

Integrating Trials into Routine Care

Almacs Clinical Technologies Division Undergoes Successful Joint GCP-GMP MHRA Inspection